Cardiol Therapeutics Inc. - Class A Common Shares (NQ:CRDL)
1.155
-0.045
(-3.75%)
Streaming Delayed Price
Updated: 1:47 PM EDT, Jul 29, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 556,090 |
| Open | 1.200 |
| Bid (Size) | 1.150 (1,800) |
| Ask (Size) | 1.160 (2,200) |
| Prev. Close | 1.200 |
| Today's Range | 1.145 - 1.210 |
| 52wk Range | 0.8800 - 1.710 |
| Shares Outstanding | 65,352,279 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
3 Penny Stocks Ready to Break Out in 2025
November 29, 2024
Healthcare and Biotech Stocks to Watch: MODD, CRDL, DBVT, VRAX
October 23, 2024
Frequently Asked Questions
Is Cardiol Therapeutics Inc. - Class A Common Shares publicly traded?
Yes, Cardiol Therapeutics Inc. - Class A Common Shares is publicly traded.
What exchange does Cardiol Therapeutics Inc. - Class A Common Shares trade on?
Cardiol Therapeutics Inc. - Class A Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Cardiol Therapeutics Inc. - Class A Common Shares?
The ticker symbol for Cardiol Therapeutics Inc. - Class A Common Shares is CRDL on the Nasdaq Stock Market
What is the current price of Cardiol Therapeutics Inc. - Class A Common Shares?
The current price of Cardiol Therapeutics Inc. - Class A Common Shares is 1.155
When was Cardiol Therapeutics Inc. - Class A Common Shares last traded?
The last trade of Cardiol Therapeutics Inc. - Class A Common Shares was at 07/29/26 01:47 PM ET
What is the market capitalization of Cardiol Therapeutics Inc. - Class A Common Shares?
The market capitalization of Cardiol Therapeutics Inc. - Class A Common Shares is 75.48M
How many shares of Cardiol Therapeutics Inc. - Class A Common Shares are outstanding?
Cardiol Therapeutics Inc. - Class A Common Shares has 75M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube